Westwood Holdings Group Inc. Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Westwood Holdings Group Inc. raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 9.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 201,651 shares of the medical device company’s stock after acquiring an additional 17,639 shares during the quarter. Westwood Holdings Group Inc. owned approximately 0.10% of Cooper Companies worth $17,604,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in COO. Vanguard Group Inc. boosted its position in Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after acquiring an additional 17,367,502 shares during the last quarter. Capital World Investors grew its position in shares of Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after purchasing an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after purchasing an additional 2,532,186 shares during the last quarter. Bessemer Group Inc. lifted its position in Cooper Companies by 305.2% during the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after buying an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB acquired a new position in Cooper Companies during the first quarter worth $139,246,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.5 %

COO stock opened at $110.49 on Friday. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The company has a fifty day moving average of $97.93 and a 200-day moving average of $95.50. The stock has a market capitalization of $22.00 billion, a PE ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the business posted $0.84 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on COO. Piper Sandler boosted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 target price (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Wells Fargo & Company raised their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Morgan Stanley upped their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Tuesday, September 10th. Finally, Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and raised their target price for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $115.00.

Insider Buying and Selling at Cooper Companies

In other news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The disclosure for this sale can be found here. In the last three months, insiders sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is owned by corporate insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.